{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:36:41Z","timestamp":1791581801357,"version":"4.3.4"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Thromboembolic diseases are increasing worldwide and always require anticoagulant therapy. We still need safer and more secure antithrombotic drugs than those presently available. Sulfated polysaccharides from marine organisms may constitute a new source for the development of such drugs. Investigation of these compounds usually attempts to reproduce the therapeutic effects of heparin. However, we may need to follow different routes, focusing particularly in the following aspects: (1) defining precisely the specific structures required for interaction of these sulfated polysaccharides with proteins of the coagulation system; (2) looking for alternative mechanisms of action, distinct from those of heparin; (3) identifying side effects (mostly pro-coagulant action and hypotension rather than bleeding) and preparing derivatives that retain the desired antithrombotic action but are devoid of side effects; (4) considering that sulfated polysaccharides with low anticoagulant action on in vitro assays may display potent effects on animal models of experimental thrombosis; and finally (5) investigating the antithrombotic effect of these sulfated polysaccharides after oral administration or preparing derivatives that may achieve this effect. If these aspects are successfully addressed, sulfated polysaccharides from marine organisms may conquer the frontier of antithrombotic therapy and open new avenues for treatment or prevention of thromboembolic diseases.<\/jats:p>","DOI":"10.3390\/md13052770","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T10:58:41Z","timestamp":1430909921000},"page":"2770-2784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs"],"prefix":"10.3390","volume":"13","author":[{"given":"Paulo","family":"Mour\u00e3o","sequence":"first","affiliation":[{"name":"Connective Tissue Research Laboratory, University Hospital Clementino Fraga Filho, Rio de Janeiro, RJ 21941-590, Brazil"},{"name":"Program of Glycobiology, Institute of Medical Biochemistry, Federal University of Rio de Janeiro, Caixa Postal 68041, Rio de Janeiro, RJ 21941-590, Brazil\u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1503\/cmaj.111795","article-title":"100 years. Looking back. Skill, drive and luck: The discovery and development of heparin","volume":"13","author":"Norma","year":"2011","journal-title":"CMAJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1055\/s-0037-1614170","article-title":"Characterization of unfractionated heparin: Comparison of materials from the last 50 years","volume":"84","author":"Mulloy","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/157489009789152212","article-title":"Heparin-coated extracorporeal circulation systems in heart surgery","volume":"4","author":"Tagarakis","year":"2009","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1055\/s-0037-1619661","article-title":"Monitoring of the heparin therapy during acute haemodialysis","volume":"25","author":"Molitor","year":"2005","journal-title":"Hamostaseologie"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-642-23056-1_10","article-title":"Adverse Effects of Heparin","volume":"207","author":"Alban","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_6","unstructured":"Introduction of Proposal for Reintroduction of Bovine Heparin to the U.S Market, Available online: http:\/\/www.fda.gov\/downloads\/UCM399418.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1160\/TH09-11-0761","article-title":"Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?","volume":"103","author":"Aquino","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajic.2010.08.020","article-title":"Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: A multi-state report","volume":"39","author":"Chemaly","year":"2011","journal-title":"Am. J. Infect. Control"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0102-76382008000200004","article-title":"Heparin quality control in the Brazilian market: Implications in the cardiovascular surgery","volume":"23","author":"Melo","year":"2008","journal-title":"Rev. Bras. Cir. Cardiovasc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2174\/1381612043452730","article-title":"Use of sulfated fucans as anticoagulant and antithrombotic agents: Future perspectives","volume":"10","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/glycob\/cwn085","article-title":"Structure, biology, evolution, and medical importance of sulfated fucans and galactans","volume":"18","author":"Pomin","year":"2008","journal-title":"Glycobiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0100-879X2007000100002","article-title":"A carbohydrate-based mechanism of species recognition in sea urchin fertilization","volume":"40","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0268-005X(98)00018-6","article-title":"Structural analysis of red seaweed galactans of agar and carrageenan groups","volume":"12","author":"Usov","year":"1998","journal-title":"Food Hydrocoll."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"29299","DOI":"10.1074\/jbc.M002422200","article-title":"Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates","volume":"275","author":"Farias","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1011142124213","article-title":"Developments on gelling algal galactans, their structure and physico-chemistry","volume":"13","author":"Lahaye","year":"2001","journal-title":"J. Appl. Phycol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.carres.2005.05.018","article-title":"Structure and anticoagulant activity of a sulfated galactan from the red alga, Gelidium crinale. Is there a specific structural requirement for the anticoagulant action?","volume":"340","author":"Pereira","year":"2005","journal-title":"Carbohydr. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jth.12448","article-title":"Is the antithrombotic effect of sulfated galactans independent of serpin?","volume":"12","author":"Santos","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1074\/jbc.272.11.6965","article-title":"Sulfated polysaccharides from the egg jelly layer are species-specific inducers of acrosomal reaction in sperms of sea urchins","volume":"272","author":"Alves","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"18790","DOI":"10.1074\/jbc.M109.005702","article-title":"A unique 2-sulfated \u03b2-galactan from the egg jelly of the sea urchin Glyptocidaris crenularis: Conformational flexibily versus induction of the sperm acrosome reaction","volume":"284","author":"Castro","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0008-6215(99)00127-5","article-title":"Further data on the structure of brown seaweed fucans: Relationships with anticoagulant activity","volume":"319","author":"Chevolot","year":"1999","journal-title":"Carbohydr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0008-6215(00)00314-1","article-title":"A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae","volume":"330","author":"Chevolot","year":"2000","journal-title":"Carbohydr. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0008-6215(02)00053-8","article-title":"Structure of a fucoidan from the brown seaweed Fucus evanescens","volume":"337","author":"Bilan","year":"2002","journal-title":"Carbohydr. Res."},{"key":"ref_25","first-page":"225","article-title":"Structure of the sulfated \u03b1-l-fucan from the egg jelly coat of the sea urchin Strongylocentrotus franciscanus: Patterns of preferential 2-O- and 4-O-sulfation determine sperm cell recognition","volume":"9","author":"Alves","year":"1999","journal-title":"Glycobiology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1074\/jbc.M108496200","article-title":"Sulfated fucans from the egg jellies of the closely related sea urchins Strongylocentrotus droebachiensis and Strongylocentrotus pallidus ensure species specific fertilization","volume":"277","author":"Castro","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0049-3848(93)90191-P","article-title":"Preparation of oversulfated fucoidans fragments and evaluation of their antithrombotic activities","volume":"72","author":"Soeda","year":"1993","journal-title":"Thromb. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0049-3848(00)00338-8","article-title":"Relationship between sulfate groups and biological activities of fucans","volume":"100","author":"Ellouali","year":"2000","journal-title":"Thromb. Res."},{"key":"ref_29","first-page":"347","article-title":"The anticoagulant and antithrombotic mechanisms of heparin","volume":"207","author":"Gray","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20824","DOI":"10.1074\/jbc.M308688200","article-title":"Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: Different mechanisms for heparin and sulfated galactans","volume":"279","author":"Melo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_31","first-page":"994","article-title":"Effects of oversulfated and fucosylated chondroitin sulfates on coagulation, Challenges for the study of anticoagulant polysaccharides","volume":"103","author":"Fonseca","year":"2010","journal-title":"Thromb. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/glycob\/cwf077","article-title":"Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans?","volume":"12","author":"Pereira","year":"2002","journal-title":"Glycobiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"23973","DOI":"10.1074\/jbc.271.39.23973","article-title":"Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm: Sulfated fucose branches on the polysaccharide account for its high anticoagulant activity","volume":"271","author":"Pereira","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0008-6215(00)90981-9","article-title":"A sulfated \u03b1-l-fucan from sea cucumber","volume":"255","author":"Ribeiro","year":"1994","journal-title":"Carbohydr. Res."},{"key":"ref_35","first-page":"829","article-title":"Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications","volume":"102","author":"Fonseca","year":"2009","journal-title":"Thromb. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/S0008-6215(02)00215-X","article-title":"A 2-sulfated, 3-linked \u03b1-l-galactan is an anticoagulante polysaccharide","volume":"337","author":"Pereira","year":"2002","journal-title":"Carbohydr. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1160\/TH08-04-0210","article-title":"Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate","volume":"100","author":"Glauser","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1160\/TH09-04-0273","article-title":"Anticoagulant activity of a sulfated galactan: Serpin-independent effect and specific interaction with factor Xa","volume":"102","author":"Glauser","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1160\/TH07-10-0649","article-title":"Sulfated galactan has an unusual effect on thrombosis due to activation of factor XII and inhibition of the coagulation proteases","volume":"99","author":"Melo","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1160\/TH05-05-0361","article-title":"Improved coagulation in bleeding disorders by non-anticoagulant sulfated polysaccharides (NASP)","volume":"95","author":"Liu","year":"2006","journal-title":"Thromb. Haemostas."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1160\/TH13-08-0635","article-title":"Structure-activity relationship of the pro- and anticoagulant effects of Fucus vesiculosus fucoidan","volume":"111","author":"Zhang","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1055\/s-0037-1616760","article-title":"Dual effects of sulfated d-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation","volume":"86","author":"Farias","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: A systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_44","first-page":"229","article-title":"On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage","volume":"22","author":"Holster","year":"2013","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/md9101731","article-title":"Therapies from fucoidan; multifunctional marine polymers","volume":"9","author":"Fitton","year":"2011","journal-title":"Mar. Drugs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1079\/BJN19960129","article-title":"In vitro fermentation by human fecal bacteria of total and purified dietary fibers from brown seaweeds","volume":"75","author":"Michel","year":"1996","journal-title":"Br. J. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1265\/jjh.46.788","article-title":"Digestibility and energy availability of Wakame (Undaria pinnatifida) seaweed in Japanese","volume":"46","author":"Yamada","year":"1991","journal-title":"Nippon Eiseigaku Zasshi"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1160\/TH06-06-0304","article-title":"Fucosylated chondroitin sulfate as a new oral antithrombotic agent","volume":"96","author":"Fonseca","year":"2006","journal-title":"Thromb. Haemost."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/md13010048","article-title":"Intestinal absorption of fucoidan extracted from the brown seaweed, Cladosiphono kamuranus","volume":"13","author":"Nagamine","year":"2015","journal-title":"Mar. Drugs"}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/13\/5\/2770\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:45:50Z","timestamp":1760215550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/13\/5\/2770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"alternative-id":["md13052770"],"URL":"https:\/\/doi.org\/10.3390\/md13052770","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}